CD44 and cancer: This creates a feedback loop where SPP1 activates the SPP1/CD44 axis and downstream PI3K/AKT and MAPK pathways, promoting epithelial-mesenchymal transition (EMT), autophagy, aberrant glucose metabolism, and reduced drug uptake in cancer cells.